SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-052719
Filing Date
2019-10-07
Accepted
2019-10-07 19:07:37
Documents
2
Period of Report
2019-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1646
2 POA DOCUMENT poa.txt EX-24.3_875567 3968
  Complete submission text file 0001209191-19-052719.txt   7223
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Issuer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PHASEBIO PHARMACEUTICALS, INC. 1 GREAT VALLEY PKWY., SUITE 30 MALVERN PA 19355
Business Address
Hanson Kristopher (Reporting) CIK: 0001789970 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38697 | Film No.: 191141652